Lipoprotein(a) (LP(a))-discovered by Kare Berg [1] in 1963-is of increasing importance in clinical routine as reflected by the ESC/EAS Guidelines for the Management of Dyslipidaemias and the recent AHA Guideline [2, 3].These guidelines provide detailed recommendations for screening and lipid analyses in the assessment of cardiovascular risk.A consensus paper of the European Society of Cardiology summarizes basic principles, background as well as diagnostic and therapeutic principles [4].This article is part of the special issue "Lp(a) -Update 2018"
No takes yet. Share an insight, caveat, or question.
Mellwig et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: